Targeting α-synuclein: Therapeutic options.
Dehay B, Decressac M, Bourdenx M, Guadagnino I, Fernagut PO, Tamburrino A, Bassil F, Meissner WG, Bezard E.
Dehay B, et al. Among authors: bassil f.
Mov Disord. 2016 Jun;31(6):882-8. doi: 10.1002/mds.26568. Epub 2016 Mar 1.
Mov Disord. 2016.
PMID: 26926119
Review.